AI in Precision Oncology: A Paradigm Shift
AI in Precision Oncology: A Paradigm Shift Targeted Oncology
AI in Precision Oncology: A Paradigm Shift Targeted Oncology
30-летняя Алена Рапунцель: «У меня рак 4-й стадии. У детей не осталось дома и денег» StarHit
How Do You Measure the Value of Donor-Funded Oncology Research? - Conquer Cancer, the ASCO Foundation Oncodaily
Human-Based Tumor Model Shows Promise for Personalized Cancer Treatment Physicians Committee for Responsible Medicine
Myelodysplastic syndromes (MDS) belong to the malignant diseases of the hematopoietic system that occur primarily in older adults. In patients with MDS, blood formation in bone marrow is impaired. Medical care therefore typically focuses on blood counts and the treatment of the resulting anemia and other changes in…
“Because of my health, I have a profound desire to see this endowment come to fruition now” The Cancer Letter
New technology lets cancer researchers watch experiments unfold in real time The Cancer Letter
Назван молочный продукт, который может защитить от рака Cursorinfo
Назван молочный продукт, который может защитить от рака Cursorinfo
EORTC Breast Cancer Group – People Moving Breast Cancer Research Forward Oncodaily
Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South Florida Health and Tampa General Hospital, have uncovered an important mechanism behind immune evasion in metastatic colorectal cancer (mCRC). Their findings challenge a 30-year-old theory about…
Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use “Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval The Cancer Letter
NCCN publishes guidelines for pediatric Ewing sarcoma The Cancer Letter
FDA Approves Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer Oncology News Central